Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus

Retrovirology

Volumn 9, Issue , 2012, Pages

  Stewart, Hazel ^a   Adema, Karen W ^a   McMonagle, Elizabeth L ^a   Hosie, Margaret J ^a   Willett, Brian J ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

Anaemia; Feline leukaemia virus; FeLV; Receptor

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GP70 ANTIBODY; NUCLEIC ACID; PROTEIN ANTIBODY; THTR1 RECEPTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BIOENGINEERING; CAT; CONTROLLED STUDY; FELINE LEUKEMIA VIRUS; FELINE LEUKEMIA VIRUS A; FELINE LEUKEMIA VIRUS C; GUINEA PIG; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; MOLECULAR EVOLUTION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR BINDING; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CATS; CELL LINE; CLONING, MOLECULAR; FIBROBLASTS; GLYCOPROTEINS; GUINEA PIGS; HEK293 CELLS; HUMANS; LEUKEMIA VIRUS, FELINE; LEUKEMIA VIRUS, MURINE; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; PROTEIN BINDING; RECEPTORS, VIRUS; RNA, VIRAL; SELECTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION; VIRUS REPLICATION;

CAVIA; FELIDAE; MURINAE; SUBGROUP A; SUBGROUP C;

EID: 84861620818     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-48     Document Type: Article

References (54)

1. Hardy WD, Hess PW, MacEwen EG, McClelland AJ, Zuckerman EE, Essex M, Cotter SM, Jarrett O. Biology of feline leukemia virus in the natural environment. Cancer Res 1976, 36:582-588.
2. Hardy WD, Hirshaut Y, Hess P. Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Bibl Haematol 1973, 39:778-799.
3. Hardy WD, Old LJ, Hess PW, Essex M, Cotter S. Horizontal transmission of feline leukaemia virus. Nature 1973, 244:266-269. 10.1038/244266a0, 4147636.
4. Riedel N, Hoover EA, Gasper PW, Nicolson MO, Mullins JI. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol 1986, 60:242-250. 253922, 3018287.
5. Mullins JI, Casey JW, Nicolson MO, Burck KB, Davidson N. Sequence arrangement and biological activity of cloned feline leukemia virus proviruses from a virus-productive human cell line. J Virol 1981, 38:688-703. 171199, 6264136.
6. Donahue PR, Hoover EA, Beltz GA, Riedel N, Hirsch VM, Overbaugh J, Mullins JI. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol 1988, 62:722-731. 253625, 2828667.
7. Hoover EA, Mullins JI. Feline leukemia virus infection and diseases. J Am Vet Med Assoc 1991, 199:1287-1297.
8. Pedersen NC, Theilen G, Keane MA, Fairbanks L, Mason T, Orser B, Che CH, Allison C. Studies of naturally transmitted feline leukemia virus infection. Am J Vet Res 1977, 38:1523-1531.
9. Mackey L, Jarrett W, Jarrett O, Laird H. Anemia associated with feline leukemia virus infection in cats. J Natl Cancer Inst 1975, 54:209-217.
10. Reinacher M. Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats. Vet Immunol Immunopathol 1989, 21:85-95. 10.1016/0165-2427(89)90132-3, 2549696.
11. Chandhasin C, Coan PN, Levy LS. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol 2005, 79:1351-1360. 10.1128/JVI.79.3.1351-1360.2005, 544135, 15650161.
12. Jarrett O. Pathogenicity of feline leukemia virus is commonly associated with variant viruses. Leukemia 1992, 6(Suppl 3):153S-154S.
13. Stewart MA, Warnock M, Wheeler A, Wilkie N, Mullins JI, Onions DE, Neil JC. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol 1986, 58:825-834. 252989, 3009890.
14. Rigby MA, Rojko JL, Stewart MA, Kociba GJ, Cheney CM, Rezanka LJ, Mathes LE, Hartke JR, Jarrett O, Neil JC. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol 1992, 73(Pt 11):2839-2847.
15. Jarrett O, Russell PH. Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer 1978, 21:466-472. 10.1002/ijc.2910210411, 208983.
16. Jarrett O, Hardy WD, Golder MC, Hay D. The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer 1978, 21:334-337. 10.1002/ijc.2910210314, 204584.
17. Sarma PS, Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. Virology 1973, 54:160-169. 10.1016/0042-6822(73)90125-6, 4351607.
18. Jarrett O, Golder MC, Toth S, Onions DE, Stewart MF. Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia. Int J Cancer 1984, 34:283-288. 10.1002/ijc.2910340222, 6088406.
19. Onions D, Jarrett O, Testa N, Frassoni F, Toth S. Selective effect of feline leukaemia virus on early erythroid precursors. Nature 1982, 296:156-158. 10.1038/296156a0, 6278316.
20. Mendoza R, Anderson MM, Overbaugh J. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J Virol 2006, 80:3378-3385. 10.1128/JVI.80.7.3378-3385.2006, 1440375, 16537605.
21. Tailor CS, Willett BJ, Kabat D. A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol 1999, 73:6500-6505. 112732, 10400745.
22. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, Sabath DE, Berg CL, Sassa S, Wood BL, Abkowitz JL. Identification of a human heme exporter that is essential for erythropoiesis. Cell 2004, 118:757-766. 10.1016/j.cell.2004.08.014, 15369674.
23. Quigley JG, Burns CC, Anderson MM, Lynch ED, Sabo KM, Overbaugh J, Abkowitz JL. Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 2000, 95:1093-1099.
24. Dean GA, Groshek PM, Mullins JI, Hoover EA. Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus. J Virol 1992, 66:5561-5568. 289115, 1323710.
25. Jarrett O, Laird HM, Hay D. Growth of feline leukaemia virus in human, canine and porcine cells. Comparative Leukaemia Research 1969, 387-392. Karger, Basel/Munchen/Paris/New York, Dutcher RM.
26. Jarrett O, Laird HM, Hay D. Determinants of the host range of feline leukaemia viruses. J Gen Virol 1973, 20:169-175. 10.1099/0022-1317-20-2-169, 4127732.
27. Boomer S, Eiden M, Burns CC, Overbaugh J. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J Virol 1997, 71:8116-8123. 192267, 9343161.
28. Riedel N, Hoover EA, Dornsife RE, Mullins JI. Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci USA 1988, 85:2758-2762. 10.1073/pnas.85.8.2758, 280078, 2833751.
29. Brojatsch J, Kristal BS, Viglianti GA, Khiroya R, Hoover EA, Mullins JI. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci USA 1992, 89:8457-8461. 10.1073/pnas.89.18.8457, 49939, 1326757.
30. Shalev Z, Duffy SP, Adema KW, Prasad R, Hussain N, Willett BJ, Tailor CS. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection. J Virol 2009, 83:6706-6716. 10.1128/JVI.02317-08, 2698567, 19369334.
31. Phipps AJ, Chen H, Hayes KA, Roy-Burman P, Mathes LE. Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A. J Virol 2000, 74:5796-5801. 10.1128/JVI.74.13.5796-5801.2000, 112073, 10846058.
32. Chen H, Bechtel MK, Shi Y, Phipps A, Mathes LE, Hayes KA, Roy-Burman P. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA). J Virol 1998, 72:7048-7056. 109925, 9696797.
33. Levesque KS, Bonham L, Levy LS. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol 1990, 64:3455-3462. 249607, 2161948.
34. Russell PH, Jarrett O. An improved assay for feline leukaemia virus pseudotypes of murine sarcoma virus. J Gen Virol 1976, 31:139-143. 10.1099/0022-1317-31-1-139, 177726.
35. Hussain N, Thickett KR, Na H, Leung C, Tailor CS. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component. J Virol 2011, 85:12529-12536. 10.1128/JVI.00822-11, 3209382, 21917946.
36. Pandey R, Ghosh AK, Kumar DV, Bachman BA, Shibata D, Roy-Burman P. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses. J Virol 1991, 65:6495-6508. 250696, 1658356.
37. Sheets RL, Pandey R, Klement V, Grant CK, Roy-Burman P. Biologically selected recombinants between feline leukemia virus (FeLV) subgroup A and an endogenous FeLV element. Virology 1992, 190:849-855. 10.1016/0042-6822(92)90924-E, 1381539.
38. Bolin LL, Chandhasin C, Lobelle-Rich PA, Albritton LM, Levy LS. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum. Retrovirology 2011, 8:35. 10.1186/1742-4690-8-35, 3113301, 21569491.
39. McDougall AS, Terry A, Tzavaras T, Cheney C, Rojko J, Neil JC. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol 1994, 68:2151-2160. 236690, 8138999.
40. Anderson MM, Lauring AS, Burns CC, Overbaugh J. Identification of a cellular cofactor required for infection by feline leukemia virus. Science 2000, 287:1828-1830. 10.1126/science.287.5459.1828, 10710311.
41. Svarovskaia ES, Cheslock SR, Zhang WH, Hu WS, Pathak VK. Retroviral mutation rates and reverse transcriptase fidelity. Front Biosci 2003, 8:d117-134. 10.2741/957, 12456349.
42. Geret CP, Cattori V, Meli ML, Riond B, Martinez F, Lopez G, Vargas A, Simon MA, Lopez-Bao JV, Hofmann-Lehmann R, Lutz H. Feline leukemia virus outbreak in the critically endangered Iberian lynx (Lynx pardinus): high-throughput sequencing of envelope variable region A and experimental transmission. Arch Virol 2011, 156:839-854. 10.1007/s00705-011-0925-z, 21302124.
43. Munk C, Beck T, Zielonka J, Hotz-Wagenblatt A, Chareza S, Battenberg M, Thielebein J, Cichutek K, Bravo IG, O'Brien SJ, et al. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol 2008, 9:R48. 10.1186/gb-2008-9-3-r48, 2397500, 18315870.
44. Nakowitsch S, Quendler H, Fekete H, Kunert R, Katinger H, Stiegler G. HIV-1 mutants escaping neutralization by the human antibodies 2 F5, 2 G12, and 4E10: in vitro experiments versus clinical studies. AIDS 2005, 19:1957-1966. 10.1097/01.aids.0000189856.13817.76, 16260901.
45. Rwambo PM, Issel CJ, Hussain KA, Montelaro RC. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Arch Virol 1990, 111:275-280. 10.1007/BF01311062, 1693846.
46. Manrique A, Rusert P, Joos B, Fischer M, Kuster H, Leemann C, Niederost B, Weber R, Stiegler G, Katinger H, et al. In vivo and in vitro escape from neutralizing antibodies 2 G12, 2 F5, and 4E10. J Virol 2007, 81:8793-8808. 10.1128/JVI.00598-07, 1951363, 17567707.
47. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977, 36:59-74. 10.1099/0022-1317-36-1-59, 886304.
48. Ohashi T, Boggs S, Robbins P, Bahnson A, Patrene K, Wei FS, Wei JF, Li J, Lucht L, Fei Y, et al. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc Natl Acad Sci USA 1992, 89:11332-11336. 10.1073/pnas.89.23.11332, 50544, 1454816.
49. Towers G, Bock M, Martin S, Takeuchi Y, Stoye JP, Danos O. A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci USA 2000, 97:12295-12299. 10.1073/pnas.200286297, 17335, 11027299.
50. Brown JK, Fung C, Tailor CS. Comprehensive mapping of receptor-functioning domains in feline leukemia virus subgroup C receptor FLVCR1. J Virol 2006, 80:1742-1751. 10.1128/JVI.80.4.1742-1751.2006, 1367145, 16439531.
51. Rey MA, Duffy SP, Brown JK, Kennedy JA, Dick JE, Dror Y, Tailor CS. Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis. Haematologica 2008, 93:1617-1626. 10.3324/haematol.13359, 18815190.
52. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J, Marquet M, Hobart P, et al. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 1996, 7:1205-1217. 10.1089/hum.1996.7.10-1205, 8793545.
53. Spiller OB, Mark L, Blue CE, Proctor DG, Aitken JA, Blom AM, Blackbourn DJ. Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J Virol 2006, 80:4068-4078. 10.1128/JVI.80.8.4068-4078.2006, 1440425, 16571823.
54. Gouy M, Guindon S, Gascuel O. SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol 2010, 27:221-224. 10.1093/molbev/msp259, 19854763.